Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-251-1 | CAS number: 10101-50-5
Endpoint summary
Administrative data
Description of key information
In accordance with Column 2 of REACH Annex VII, information requirement section 8.3, this study does not need to be conducted if the substance is classified as skin corrosion (Category 1).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because the substance is classified as skin corrosion (Category 1, 1A, 1B or 1C)
- Justification for type of information:
- In accordance with Column 2 of REACH Annex VII, information requirement section 8.3, this study does not need to be conducted if the substance is classified as skin corrosion (Category 1).
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because the substance is classified as skin corrosion (Category 1, 1A, 1B or 1C)
- Justification for type of information:
- In accordance with Column 2 of REACH Annex VII, information requirement section 8.3, this study does not need to be conducted if the substance is classified as skin corrosion (Category 1).
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no study available
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
There are no currently validated studies of respiratory sensitisation and no reports of occupational asthma in exposed workers. The local effects of inhalation exposure to sodium permanganate will be dominated by respiratory tract irritation and other efefcts are unlikely.
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No 1272/2008, the material does not require classification with respect to skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
